101 related articles for article (PubMed ID: 8302572)
1. The viral and cellular Rel oncoproteins induce the differentiation of P19 embryonal carcinoma cells.
Inuzuka M; Ishikawa H; Kumar S; Gélinas C; Ito Y
Oncogene; 1994 Jan; 9(1):133-40. PubMed ID: 8302572
[TBL] [Abstract][Full Text] [Related]
2. Two novel functions associated with the Rel oncoproteins: DNA replication and cell-specific transcriptional activation.
Ishikawa H; Asano M; Kanda T; Kumar S; Gélinas C; Ito Y
Oncogene; 1993 Nov; 8(11):2889-96. PubMed ID: 8414493
[TBL] [Abstract][Full Text] [Related]
3. The v-Rel oncoprotein increases expression from Sp1 site-containing promoters in chicken embryo fibroblasts.
Sif S; Capobianco AJ; Gilmore TD
Oncogene; 1993 Sep; 8(9):2501-9. PubMed ID: 8361761
[TBL] [Abstract][Full Text] [Related]
4. v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence.
Mosialos G; Gilmore TD
Oncogene; 1993 Mar; 8(3):721-30. PubMed ID: 8437855
[TBL] [Abstract][Full Text] [Related]
5. Selective activation of the proto-oncogene c-jun promoter by the transforming protein v-Rel.
Fujii M; Minamino T; Nomura M; Miyamoto KI; Tanaka J; Seiki M
Oncogene; 1996 May; 12(10):2193-202. PubMed ID: 8668346
[TBL] [Abstract][Full Text] [Related]
6. Rel blocks both anti-Fas- and TNF alpha-induced apoptosis and an intact Rel transactivation domain is essential for this effect.
Zong WX; Bash J; Gélinas C
Cell Death Differ; 1998 Nov; 5(11):963-72. PubMed ID: 9846183
[TBL] [Abstract][Full Text] [Related]
7. Structure of a mammalian c-rel protein deduced from the nucleotide sequence of murine cDNA clones.
Grumont RJ; Gerondakis S
Oncogene Res; 1989; 4(1):1-8. PubMed ID: 2654811
[TBL] [Abstract][Full Text] [Related]
8. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.
Carrasco D; Rizzo CA; Dorfman K; Bravo R
EMBO J; 1996 Jul; 15(14):3640-50. PubMed ID: 8670867
[TBL] [Abstract][Full Text] [Related]
9. A chicken c-Rel-estrogen receptor chimeric protein shows conditional nuclear localization, DNA binding, transformation and transcriptional activation.
Zurovec M; Petrenko O; Roll R; Enrietto PJ
Oncogene; 1998 Jun; 16(24):3133-42. PubMed ID: 9671392
[TBL] [Abstract][Full Text] [Related]
10. An optimal range of transcription potency is necessary for efficient cell transformation by c-Rel to ensure optimal nuclear localization and gene-specific activation.
Fan Y; Gélinas C
Oncogene; 2007 Jun; 26(27):4038-43. PubMed ID: 17173064
[TBL] [Abstract][Full Text] [Related]
11. The int-1 proto-oncogene is transcriptionally activated during neuroectodermal differentiation of P19 mouse embryonal carcinoma cells.
St-Arnaud R; Craig J; McBurney MW; Papkoff J
Oncogene; 1989 Sep; 4(9):1077-80. PubMed ID: 2674852
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of the Wilms' tumor gene, WT1, during differentiation of embryonal carcinoma and embryonic stem cells.
Scharnhorst V; Kranenburg O; van der Eb AJ; Jochemsen AG
Cell Growth Differ; 1997 Feb; 8(2):133-43. PubMed ID: 9040935
[TBL] [Abstract][Full Text] [Related]
13. Classification of neural differentiation-associated genes in P19 embryonal carcinoma cells by their expression patterns induced after cell aggregation and/or retinoic acid treatment.
Teramoto S; Kihara-Negishi F; Sakurai T; Yamada T; Hashimoto-Tamaoki T; Tamura S; Kohno S; Oikawa T
Oncol Rep; 2005 Nov; 14(5):1231-8. PubMed ID: 16211290
[TBL] [Abstract][Full Text] [Related]
14. The role of the carboxy terminus of v-Rel in transformation and activation of endogenous gene expression.
Smardova J; Walker A; Morrison LE; Kabrun N; Enrietto PJ
Oncogene; 1995 May; 10(10):2017-26. PubMed ID: 7761102
[TBL] [Abstract][Full Text] [Related]
15. Characterization of changes in gene expression associated with malignant transformation by the NF-kappaB family member, v-Rel.
Petrenko O; Ischenko I; Enrietto PJ
Oncogene; 1997 Oct; 15(14):1671-80. PubMed ID: 9349500
[TBL] [Abstract][Full Text] [Related]
16. Expression of the met/hepatocyte growth factor/scatter factor receptor and its ligand during differentiation of murine P19 embryonal carcinoma cells.
Yang XM; Park M
Dev Biol; 1993 Jun; 157(2):308-20. PubMed ID: 8388815
[TBL] [Abstract][Full Text] [Related]
17. v-Rel prevents apoptosis in transformed lymphoid cells and blocks TNFalpha-induced cell death.
Zong WX; Farrell M; Bash J; Gélinas C
Oncogene; 1997 Aug; 15(8):971-80. PubMed ID: 9285692
[TBL] [Abstract][Full Text] [Related]
18. Differences in kappaB DNA-binding properties of v-Rel and c-Rel are the result of oncogenic mutations in three distinct functional regions of the Rel protein.
Nehyba J; Hrdlicková R; Bose HR
Oncogene; 1997 Jun; 14(24):2881-97. PubMed ID: 9205096
[TBL] [Abstract][Full Text] [Related]
19. The rel family of proteins.
Rushlow C; Warrior R
Bioessays; 1992 Feb; 14(2):89-95. PubMed ID: 1533515
[TBL] [Abstract][Full Text] [Related]
20. Mutant envelope residues confer a transactivation function onto N-terminal sequences of the v-Rel oncoprotein.
Epinat JC; Kazandjian D; Harkness DD; Petros S; Dave J; White DW; Gilmore TD
Oncogene; 2000 Feb; 19(5):599-607. PubMed ID: 10698504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
